Apr 4, 2023 4:05 pm EDT iBio Discovers New Panel of CD3 T-Cell Binding Antibodies Using its Patented AI Epitope Steering Platform
Jan 5, 2023 8:00 am EST iBio Announces Issuance of U.S. Patent Covering AI-Engineered Epitope Discovery Engine
Dec 5, 2022 8:00 am EST iBio® to Showcase the RubrYc® Discovery Engine During Poster Presentations at Antibody Engineering & Therapeutics Conference 2022